A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

NCT04794972 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioma
Solid Tumor

Interventions

DRUG: GNC-039

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]